Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets
Yaqi Yin1, Haojie Hao2, Yu Cheng1
1Department of Endocrinology, Chinese PLA General Hospital, Beijing, China.
Abstract:
Progressive pancreatic β-cell dysfunction is recognized as a fundamental pathology of type 2 diabetes (T2D). Recently, mesenchymal stem cells (MSCs) have been identified in protection of islets function in T2D individuals. However, the underlying mechanisms remain elusive. It is widely accepted that β-cell dysfunction is closely related to improper accumulation of macrophages in the islets, and a series of reports suggest that MSCs possess great immunomodulatory properties by which they could elicit macrophages into an anti-inflammatory M2 state. In this study, we induced a T2D mouse model with a combination of high-fat diet (HFD) and low-dose streptozotocin (STZ), and then performed human umbilical cord-derived MSCs (hUC-MSCs) infusion to investigate whether the effect of MSCs on islets protection was related to regulation on macrophages in pancreatic islets. hUC-MSCs infusion exerted anti-diabetic effects and significantly promoted islets recovery in T2D mice. Interestingly, pancreatic inflammation was remarkably suppressed, and local M1 macrophages were directed toward an anti-inflammatory M2-like state after hUC-MSC infusion. In vitro study also proved that hUC-MSCs inhibited the activation of the M1 phenotype and induced the generation of the M2 phenotype in isolated mouse bone marrow-derived macrophages (BMDMs), peritoneal macrophages (PMs) and in THP-1 cells. Further analysis showed that M1-stimulated hUC-MSCs increased the secretion of interleukin (IL)-6, blocking which by small interfering RNA (siRNA) largely abrogated the hUC-MSCs effects on macrophages both in vitro and in vivo, resulting in dampened restoration of β-cell function and glucose homeostasis in T2D mice. In addition, MCP-1 was found to work in accordance with IL-6 in directing macrophage polarization from M1 to M2 state. These data may provide new clues for searching for the target of β-cell protection. Furthermore, hUC-MSCs may be a superior alternative in treating T2D for their macrophage polarization effects.
Insights
Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) treat type 2 diabetes (T2D) by reprogramming inflammatory M1 macrophages to an anti-inflammatory M2 state, restoring islet function and glucose control.
Area of Science:
- Immunology
- Endocrinology
- Stem Cell Biology
Background:
- Progressive pancreatic beta-cell dysfunction is central to type 2 diabetes (T2D).
- Mesenchymal stem cells (MSCs) show potential in protecting islet function, but mechanisms are unclear.
- Macrophage accumulation and polarization in islets are linked to beta-cell dysfunction.
Purpose of the Study:
- To investigate if human umbilical cord-derived MSCs (hUC-MSCs) protect islets in T2D by modulating islet macrophages.
- To explore the role of interleukin-6 (IL-6) and MCP-1 in MSC-mediated macrophage polarization.
Main Methods:
- Induced T2D mouse model using high-fat diet (HFD) and streptozotocin (STZ).
- Infused hUC-MSCs into T2D mice and analyzed pancreatic islets and macrophage phenotypes (M1/M2).
- Conducted in vitro studies with isolated macrophages and THP-1 cells, assessing IL-6 and MCP-1 involvement using siRNA.
Main Results:
- hUC-MSC infusion improved glycemic control and promoted islet recovery in T2D mice.
- Pancreatic inflammation was suppressed, with M1 macrophages shifting to an M2-like state.
- hUC-MSCs induced M2 polarization in vitro and in vivo, partly via IL-6 and MCP-1 signaling.
Conclusions:
- hUC-MSCs exert anti-diabetic effects by reprogramming islet macrophages from an M1 to an M2 phenotype.
- IL-6 and MCP-1 play crucial roles in mediating hUC-MSC-induced macrophage polarization and subsequent beta-cell protection.
- hUC-MSCs represent a promising therapeutic strategy for T2D by targeting macrophage polarization.
More Related Videos
04:09Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
07:26Isolation and Characterization of Human Umbilical Cord-derived Mesenchymal Stem Cells from Preterm and Term Infants
Published on: January 26, 2019
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Mesenchymal Stem Cells
Embryonic Stem Cells
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
